SLC7A11 and lung adenocarcinoma: Overexpression of SLC7A11 in KRAS-mutant lung adenocarcinoma (LUAD) patients is linked to increased susceptibility to SLC7A11 inhibition in cells carrying KRAS-mutant LUAD, which significantly reduces cystine uptake and intracellular glutathione biosynthesis60.